Back to All Events

Vaccines and Related Biological Products Advisory Committee

  • IQVIA Solutions Denmark A/S Denmark (map)

The US FDA has scheduled a Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting on March 03, 2022 to discuss and make recommendations on the selection of strains to be included in an influenza virus vaccine for influenza season of 2022 – 2023 influenza season.

Source:: https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-march-3-2022-meeting-announcement
Earlier Event: February 15
Joint Meeting of the Committee and the Drug Safety and Risk Management Advisory Committee
Later Event: March 10
Cellular, Tissue, and Gene Therapies Advisory Committee